347 Results

People

  1. Mauro
    Mauro
  2. Clarkson
    Clarkson
  3. Berman
    Berman
  4. O'Reilly
    O'Reilly
  5. Strife
    Strife
  6. Wisniewski
    Wisniewski
  7. Kernan
    Kernan
  8. Sawyers
    Sawyers
  9. Scheinberg
    Scheinberg
  10. Papadopoulos
    Papadopoulos

Groups

  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)
  7. Tow Center for Developmental Oncology (TCDO) (77)
  8. Molecular Pharmacology and Chemistry Program Faculty (71)
  9. Human Oncology and Pathogenesis Program (47)
  10. Pediatrics, Department of (46)
  1. "chronic myeloid leukemia"
Formats
  1. Journal Article (300)
  2. Meeting Abstract (18)
  3. Review (10)
  4. Conference Paper (8)
  5. Research Letter (6)
  6. Correspondence (2)
  7. Editorial (2)
  8. Guidelines (1)
Groups
  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)

More Groups

People
  1. Michael Mauro (56)
  2. Bayard Clarkson (40)
  3. Ellin Berman (24)
  4. Annabel Strife (20)
  5. Richard O'Reilly (20)
  6. David Wisniewski (18)

More People

Years
  1. 2025 (7)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Blood (29)
  2. Leukemia (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (19)
  4. Biology of Blood and Marrow Transplantation (17)
  5. Bone Marrow Transplantation (15)
  6. Cancer Research (14)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. Nature Publishing Group (51)
  3. American Society of Hematology (33)
  4. American Association for Cancer Research (20)
  5. John Wiley & Sons (12)
  6. Springer (12)

More Publishers

Results (347)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cognition in patients treated with targeted therapy for chronic myeloid leukemia: A controlled comparison
    Journal Article

    Hyland, K. A.; Eisel, S. L.; Hoogland, A. I.; Root, J. C.; Bowles, K.; James, B.; Nelson, A. M.; Booth-Jones, M.; Jacobsen, P. B.; Ahles, T. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • COVID-19 vaccination response and its practical application in patients with chronic lymphocytic leukemia
    Review

    Shadman, M.; Liu, C.; Eakle, K.; Hiew, H. J.; Biondo, J. M. L.; Ghia, P.; Mato, A. R.
    HemaSphere (2023)

    Fulltext@MSK | Save
  • Mitigation of gastrointestinal graft-versus-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
    Research Letter

    Chhabra, S.; Szabo, A.; Clurman, A.; McShane, K.; Waters, N.; Eastwood, D.; Samanas, L.; Fei, T.; Armijo, G.; Abedin, S.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • ASC2ESCALATE trial in progress: A phase 2 single-arm dose escalation study of asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase (CMLCP) previously treated with 1 prior tyrosine kinase inhibitor (TKI)
    Meeting Abstract

    Sasaki, K.; Mauro, M. J.; Levy, M. Y.; Atallah, E. L.; Koller, P.; Maegawa, R.; Damon, A.; Kumar, J.; Khan, M.; Cortes, J. E.
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • AIM4CML Trial in progress: A phase IIIb study of asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase (CML-CP) with and without the T315I mutation
    Meeting Abstract

    Levy, M. Y.; Mauro, M. J.; Issa, G. C.; Andorsky, D.; Tomassetti, S.; Broun, E. R.; Maegawa, R.; Deininger, M.
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Asciminib provides durable molecular responses in patients with chronic myeloid leukemia in chronic phase (CML-CP) with the T315I mutation: Updated efficacy and safety data from a phase I trial
    Meeting Abstract

    Hughes, T. P.; Cortes, J. E.; Réa, D.; Mauro, M. J.; Hochhaus, A.; Kim, D. W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults
    Journal Article

    Politikos, I.; Lau, C.; Devlin, S. M.; Quach, S.; Lin, A.; Perales, M. A.; Shah, G. L.; Seo, S. K.; Papanicolaou, G. A.; Barker, J. N.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
    Journal Article

    Burgos da Silva, M.; Ponce, D. M.; Dai, A.; Devlin, S. M.; Gomes, A. L. C.; Moore, G.; Slingerland, J.; Shouval, R.; Armijo, G. K.; DeWolf, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
    Research Letter

    Vaughn, J. L.; Brown, S.; Papadopoulos, E. B.; Jakubowski, A. A.; Tamari, R.; Giralt, S. A.; Ponce, D. M.; Cho, C.; Perales, M. A.; Shaffer, B. C.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save
  • Patient- and physician-reported pain after tyrosine kinase inhibitor discontinuation among patients with chronic myeloid leukemia
    Journal Article

    Flynn, K. E.; Atallah, E.; Lin, L.; Shah, N. P.; Silver, R. T.; Larson, R. A.; Pinilla-Ibarz, J.; Thompson, J. E.; Oehler, V. G.; Radich, J. P.; more...
    Haematologica (2022)

    Fulltext@MSK | Save